Search for: "State v. Gilead Sciences, Inc." Results 1 - 20 of 68
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Sep 2023, 2:39 am by Courtenay C. Brinckerhoff
Cellect Strategies  Some stakeholders have been expecting a decision like Cellect since the Federal Circuit first decided that a later-granted patent can raise OTDP issues for an earlier-granted patent, in its 2014 decision in Gilead Sciences, Inc. v. [read post]
14 Sep 2021, 4:00 am by Alan Macek
Gilead Sciences Canada, Inc., 2021 FCA 122, the Federal Court of Appeal considered when summary determination is appropriate, particularly when a responding party has moved to quash the motion for summary trial. [read post]
13 Aug 2021, 4:00 am by Jim Sedor
Rand Paul revealed his wife bought stock in Gilead Sciences, which makes an antiviral drug used to treat COVID-19, in February 2020, before it was classified as a pandemic by the World Health Organization. [read post]
12 May 2020, 4:00 am by Alan Macek
Gilead Sciences Canada, Inc., 2020 FC 486, another decision decided by Justice Manson, the defendant sought summary trial on the meaning of a key term of the asserted patent claims and non-infringement. [read post]
1 Dec 2019, 9:50 pm by Patent Docs
By Daniel Boehnen -- Last month, the United States government, acting on behalf of its Department of Health and Human Services (HHS), filed suit in Delaware against Gilead Sciences, Inc. and Gilead Sciences Ireland UC for infringing four patents covering inventions developed by scientists at the Centers for Disease Control and Prevention. [read post]
30 Oct 2019, 10:48 pm by Patent Docs
Gilead Sciences Inc., the Federal Circuit held that Idenix's patent was invalid on both grounds, affirming the District Court's overturning of a jury verdict on enablement and... [read post]
30 Oct 2019, 6:23 pm by Lawrence B. Ebert
Gilead Sciences Inc., (“Gilead”)argues that the patent is also invalid for failure to meet thewritten description requirement, and that the district courterred by failing to grant JMOL on that ground as well. [read post]
30 Jan 2019, 10:15 am by Gene Quinn
A sensible ruling, and one the panel explained was entirely consistent with both the PTA statute and Gilead Sciences, Inc. v. [read post]